Methanolic extract of Entada phaseoloides inhibits Colorectal carcinoma cells proliferation of HT-29 cell by Modulating mitochondria-mediated apoptotic pathway

Colorectal cancer (CRC) is among the leading three diseases with higher death rates worldwide, with an expected 2.2 million new cases continuously in 2030. The expanding utilization of common plant-inferred parts, investigating the counter proliferative impacts of phytochemicals is progressively picking up significance in planning anticancer medications. This study aimed to examine the effect of methanolic extracts of Entada phaseoloides (MEEP) on the apoptotic pathway in human colon carcinoma cells (HT-29 cells). MTT assay and live/dead staining with fluorescein diacetate/propidium iodide (FDA/PI) were utilized to quantify cell viability in cancer cells. This research facility's exploratory investigation showed the effects of colon malignant growth cells (HT-29) exposed to various portions (1.23, 3.70, 11.11, 33.33, and 100µg/mL) of MEEP. The pure compounds isolated from the extracts includes Oleic acid, Entadamide A, Entadamide A-beta-D-glucopyranoside, Phaseoloidin. The result showed that MEEP actuated the concealment of cell viability and apoptosis in HT-29 cells in a dose-dependent manner. This included characteristic changes in nuclear morphology, the breakdown of mitochondrial membrane potential (Δψm), up-regulation of pro-apoptotic BAX, and down-regulation of anti-apoptotic Bcl-2, which initiates the transformation of caspase-3 to cleaved caspase-3, thus actuating PARP promoting apoptosis. Furthermore, it was found that MEEP does not affect ROS production. Thus overall findings applies against proliferative impact through various signalling pathways, is an outstanding possibility for hostile to colon cancer therapy with the help of natural sources.